111 related articles for article (PubMed ID: 16887640)
1. Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours.
Lambin P; Theys J; Landuyt W; Rijken P; van der Kogel A; van der Schueren E; Hodgkiss R; Fowler J; Nuyts S; de Bruijn E; Van Mellaert L; Anné J
Anaerobe; 1998 Aug; 4(4):183-8. PubMed ID: 16887640
[TBL] [Abstract][Full Text] [Related]
2. Clostridium spores as anti-tumour agents.
Van Mellaert L; Barbé S; Anné J
Trends Microbiol; 2006 Apr; 14(4):190-6. PubMed ID: 16500103
[TBL] [Abstract][Full Text] [Related]
3. Clostridium as a tumor-specific delivery system of therapeutic proteins.
Theys J; Landuyt AW; Nuyts S; Van Mellaert L; Lambin P; Anné J
Cancer Detect Prev; 2001; 25(6):548-57. PubMed ID: 12132875
[TBL] [Abstract][Full Text] [Related]
4. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
5. Clostridia in cancer therapy.
Minton NP
Nat Rev Microbiol; 2003 Dec; 1(3):237-42. PubMed ID: 15035028
[TBL] [Abstract][Full Text] [Related]
6. Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment.
Barbé S; Van Mellaert L; Theys J; Geukens N; Lammertyn E; Lambin P; Anné J
FEMS Microbiol Lett; 2005 May; 246(1):67-73. PubMed ID: 15869963
[TBL] [Abstract][Full Text] [Related]
7. The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
Schmidt W; Fabricius EM; Schneeweiss U
Int J Oncol; 2006 Dec; 29(6):1479-92. PubMed ID: 17088987
[TBL] [Abstract][Full Text] [Related]
8. The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy.
Kubiak AM; Minton NP
Res Microbiol; 2015 May; 166(4):244-54. PubMed ID: 25576776
[TBL] [Abstract][Full Text] [Related]
9. The use of clostridial spores for cancer treatment.
Barbé S; Van Mellaert L; Anné J
J Appl Microbiol; 2006 Sep; 101(3):571-8. PubMed ID: 16907807
[TBL] [Abstract][Full Text] [Related]
10. [Treatment experiments with glucose-induced hyperglycaemia plus Clostridium-spores on the Jensen sarcoma of rats].
Hambsch K; Körner C; Ludewig R
Arch Geschwulstforsch; 1982; 52(4):267-73. PubMed ID: 7138239
[TBL] [Abstract][Full Text] [Related]
11. Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress.
Mowday AM; Guise CP; Ackerley DF; Minton NP; Lambin P; Dubois LJ; Theys J; Smaill JB; Patterson AV
Cancers (Basel); 2016 Jun; 8(7):. PubMed ID: 27367731
[TBL] [Abstract][Full Text] [Related]
12. A theoretical models of oncolysis by Clostridium oncolyticum M 55 ATCC 13,732.
Brantner H; Schwager J
Arch Geschwulstforsch; 1980; 50(7):601-12. PubMed ID: 6263207
[TBL] [Abstract][Full Text] [Related]
13. Clostridial spores for cancer therapy: targeting solid tumour microenvironment.
Umer B; Good D; Anné J; Duan W; Wei MQ
J Toxicol; 2012; 2012():862764. PubMed ID: 22737166
[TBL] [Abstract][Full Text] [Related]
14. Increased apoptosis and decreased proliferation of colorectal cancer cells using insulin-like growth factor binding protein-4 gene delivered locally by gene transfer.
Durai R; Yang SY; Sales KM; Seifalian AM; Goldspink G; Winslet MC
Colorectal Dis; 2007 Sep; 9(7):625-31. PubMed ID: 17824980
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of
Sharafabad BE; Abdoli A; Abdolmohammadi Khiav L; Meskini M; Jamur P; Dilmaghani A
Curr Cancer Drug Targets; 2023; 23(9):682-696. PubMed ID: 37069721
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia targeting gene expression for breast cancer gene therapy.
Lee M
Adv Drug Deliv Rev; 2009 Aug; 61(10):842-9. PubMed ID: 19426773
[TBL] [Abstract][Full Text] [Related]
17. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
19. Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment.
Weibel S; Stritzker J; Eck M; Goebel W; Szalay AA
Cell Microbiol; 2008 Jun; 10(6):1235-48. PubMed ID: 18208564
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
